Natural History of Molluscum Contagiosum Resolution
Molluscum contagiosum typically resolves spontaneously in 6 to 12 months in most children, though complete clearance can take up to 4 years in some cases. 1
Expected Timeline for Resolution
The natural history varies based on several factors:
Standard Resolution Times
- Most common timeframe: 6-12 months for spontaneous resolution 1
- Extended cases: Complete resolution can take up to 4 years 1
- By 12 months: Approximately 45-50% of cases will have cleared 2, 3
- By 18 months: Approximately 70% of cases will have cleared 2, 3
- Mean resolution time: 13.3 months (SD 8.2) based on prospective UK cohort data 2
Age-Related Differences
Children clear infections faster than adults:
- Children may clear within a few months, with half resolving by 1 year and two-thirds by 2 years 4
- Adults experience much slower clearance, with persistence for 5-10 years not uncommon 4
Factors Affecting Resolution Time
Prolonged Course Associated With:
- Immunosuppression: More severe and prolonged course in immunocompromised patients (HIV, organ transplant recipients) 5, 6
- Atopic dermatitis: Children with atopic dermatitis have significantly more lesions, though this doesn't necessarily predict longer resolution time 3
- Number of lesions: Greater lesion burden correlates with greater impact on quality of life but not necessarily longer duration 2
What Does NOT Predict Resolution Time:
Based on a 170-patient cohort study, the following factors did not predict time to resolution 3:
- Treatment versus no treatment
- Sex or race
- Number of lesions at diagnosis
- Number of anatomic locations involved
- History of atopic dermatitis
Clinical Implications
The "Watch and Wait" Approach
While spontaneous resolution is expected, this approach has significant drawbacks:
- Transmission risk: 41% transmission rate to other children in the same household 2
- Quality of life impact: 11% of children experience very severe effects on quality of life (CDLQI score >13) 2
- Prolonged infection: One-third of cases persist beyond 18 months 2
- Psychosocial burden: Increases anxiety, embarrassment, and social isolation 6, 7
When to Consider Active Treatment
Treatment should be considered for:
- Children with many lesions (associated with worse quality of life) 2
- Lesions in cosmetically sensitive areas (face) 1
- Patients with underlying eczema 1
- Any patient with identified severe quality of life impact 2
- Immunocompromised patients (higher risk of diffuse, persistent disease) 6, 7
Important Caveats
No treatment has been proven to shorten resolution time. A randomized controlled trial of 170 children showed no difference in clearance rates between treated and untreated groups at 12 months (45.6% vs 48.4%) or 18 months (69.5% vs 72.6%) 3. A Cochrane review of 22 studies (1650 participants) found no single intervention convincingly effective 8.
The "beginning of the end" (BOTE) sign: A strong inflammatory response often precedes resolution, indicating the immune system is clearing the infection 9. This can be mistaken for worsening disease but actually signals impending clearance.
Setting Realistic Expectations
Counsel patients and parents that:
- Most cases resolve within 12-18 months without treatment
- Up to 30% may persist beyond 18 months
- Treatment may help with symptoms and reduce transmission but likely won't accelerate clearance
- The infection is benign and self-limited in immunocompetent individuals